BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26647152)

  • 21. Ghrelin in human medullary thyroid carcinomas.
    Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative high-dose calcium stimulation test in patients with sporadic medullary thyroid carcinoma is highly accurate in predicting lateral neck metastases.
    De Crea C; Raffaelli M; Milano V; Carrozza C; Zuppi C; Bellantone R; Lombardi CP
    Surgery; 2016 Jan; 159(1):70-6. PubMed ID: 26456123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
    Elisei R; Bottici V; Luchetti F; Di Coscio G; Romei C; Grasso L; Miccoli P; Iacconi P; Basolo F; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2004 Jan; 89(1):163-8. PubMed ID: 14715844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature.
    Trimboli P; Giovanella L
    Clin Chem Lab Med; 2015 Sep; 53(10):1507-14. PubMed ID: 25781697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
    Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
    J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients.
    Chambon G; Alovisetti C; Idoux-Louche C; Reynaud C; Rodier M; Guedj AM; Chapuis H; Lallemant JG; Lallemant B
    J Clin Endocrinol Metab; 2011 Jan; 96(1):75-81. PubMed ID: 20881258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can procalcitonin be useful for medullary thyroid cancer?
    Kaczka K; Mikosiński S; Fendler W; Jałocha-Kaczka A; Pomorski L
    Endokrynol Pol; 2010; 61(5):430-6. PubMed ID: 21049453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mild persistent hypercalcitoninemia after total thyroidectomy in patients with papillary thyroid carcinoma.
    Yokoi K; Imai T; Shibata A; Hibi Y; Kikumori T; Funahashi H; Nakao A
    Endocr J; 2003 Aug; 50(4):453-8. PubMed ID: 14599120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum calcitonin nadirs to undetectable levels within 1 month of curative surgery in medullary thyroid cancer.
    Andrade F; Rondeau G; Boucai L; Zeuren R; Shaha AR; Ganly I; Vaisman F; Corbo R; Tuttle M
    Arch Endocrinol Metab; 2019; 63(2):137-141. PubMed ID: 30916162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcitonin levels by ECLIA correlate well with RIA values in higher range but are affected by sex, TgAb, and renal function in lower range.
    Ito Y; Kaneko H; Sasaki Y; Ohana N; Ichijo M; Furuya F; Suzuki S; Suzuki S; Shimura H
    Endocr J; 2020 Jul; 67(7):759-770. PubMed ID: 32269183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Challenges of Medullary Thyroid Carcinoma.
    Leimbach RD; Hoang TD; Shakir MKM
    Oncology; 2021; 99(7):422-432. PubMed ID: 33878761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medullary thyroid nodules by measurement of calcitonin (Ct) in aspiration needle washout in patients with multinodular goiter and moderately elevated serum Ct.
    Trimboli P; Nigri G; Romanelli F; Cicciarella Modica DD; Crescenzi A; Valabrega S; Giovanella L
    Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):234-7. PubMed ID: 22328107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements.
    Engelbach M; Görges R; Forst T; Pfützner A; Dawood R; Heerdt S; Kunt T; Bockisch A; Beyer J
    J Clin Endocrinol Metab; 2000 May; 85(5):1890-4. PubMed ID: 10843170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety.
    Mian C; Perrino M; Colombo C; Cavedon E; Pennelli G; Ferrero S; De Leo S; Sarais C; Cacciatore C; Manfredi GI; Verga U; Iacobone M; De Pasquale L; Pelizzo MR; Vicentini L; Persani L; Fugazzola L
    J Clin Endocrinol Metab; 2014 May; 99(5):1656-64. PubMed ID: 24552221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative predictive value of procalcitonin in medullary thyroid carcinoma.
    Lim SK; Guéchot J; Vaubourdolle M
    Ann Biol Clin (Paris); 2016; 74(2):213-8. PubMed ID: 26806393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of procalcitonin measurement in patients after total thyroidectomy due to medullary thyroid carcinoma.
    Bolko P; Manuszewska-Jopek E; Michałek K; Waśko R; Jaskuła M; Sowiński J
    Arch Immunol Ther Exp (Warsz); 2003; 51(6):415-9. PubMed ID: 14692663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical Treatment of Medullary Thyroid Cancer.
    Machens A; Dralle H
    Recent Results Cancer Res; 2015; 204():187-205. PubMed ID: 26494390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline and stimulated calcitonin: Thresholds for the diagnosis of medullary thyroid cancer.
    Fugazzola L
    Ann Endocrinol (Paris); 2019 Jun; 80(3):191-192. PubMed ID: 31053250
    [No Abstract]   [Full Text] [Related]  

  • 39. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical spectrum of RET proto-oncogene mutations in codon 790.
    Bihan H; Murat A; Fysekidis M; Al-Salameh A; Schwartz C; Baudin E; Thieblot P; Borson-Chazot F; Guillausseau PJ; Cardot-Bauters C; Raingeard I; Requeda E; Sadoul JL; Reznik Y;
    Eur J Endocrinol; 2013 Sep; 169(3):271-6. PubMed ID: 23756355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.